This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gazzeri, S. Articles by Brambilla, C. Search for Related Content PubMed PubMed Citation Articles by Gazzeri, S. Articles by Brambilla, C.

Activation of myc Gene Family in Human Lung Carcinomas and during Heterotransplantation into Nude Mice¹

Groupe de Recherche sur le Cancer Bronchique, Pavillon D2 [S. G., C. B.], Laboratoire d'Anatomopathologie [E. B.], Laboratoire de Cytogénétique [M. J.], and INSERM U318, Neurobiophysique, Pavillon B [C. C., A. L. B.], Université Joseph Fourier, Centre Hospitalier Albert Michallon, BP 217X, 38043 Grenoble Cedex, France

myc gene family activation (c-myc, L-myc, and N-myc) was examined in 26 human lung carcinomas and in their corresponding xenografts in nude mice. Of the 16 neuroendocrine (NE) carcinomas studied, amplification was observed in 4 with a c-myc probe and in 1 with both L- and N-myc probes. Overexpression was found in 1 of 7 cases studied for c-myc mRNA, in 1 of 7 cases for N-myc, and in 2 of 7 cases for L-myc. Of the 10 non-small cell lung carcinomas studied, only c-myc was amplified in 1 case and overexpressed in 5 of 7 cases. These results suggest that L- and N-myc gene activation are restricted to NE carcinomas. Over-expression of the myc gene without amplification was detected in 36% of cases. During heterotransplantation, there was a 27% change in myc gene abnormality and a 57% increase in myc expression levels, mostly in NE carcinomas (5 of 7; 71%). In a total of 42 xenografted lung carcinomas studied, 45% amplification and 77% overexpression of one of the myc genes were detected with a high prevalence of L-myc overexpression in NE carcinomas (50%) and of c-myc overexpression in non-small cell lung carcinomas (66%). Finally, 19 of 26 (73%) tumors are growing in nude mice with no myc gene amplification and 43% with no myc mRNA overexpression. Thus myc gene activation is not strictly required for heterotransplantation but seems to be a favorable factor in the maintenance and progression of lung carcinomas in vivo.

¹ Supported by grants from INSERM, ARC, and EPR.

² To whom requests for reprints should be addressed.

Received 7/ 9/90. Accepted 3/ 7/91.

This article has been cited by other articles:

				J. M. Serra, A. Gutierrez, R. Alemany, M. Navarro, T. Ros, C. Saus, J. Gines, A. Sampol, J. C. Amat, L. Serra-Moises, et al. Inhibition of c-Myc Down-Regulation by Sustained Extracellular Signal-Regulated Kinase Activation Prevents the Antimetabolite Methotrexate- and Gemcitabine-Induced Differentiation in Non-Small-Cell Lung Cancer Cells Mol. Pharmacol., June 1, 2008; 73(6): 1679 - 1687. [Abstract] [Full Text] [PDF]

				N. Pedersen, S. Mortensen, S. B. Sorensen, M. W. Pedersen, K. Rieneck, L. F. Bovin, and H. S. Poulsen Transcriptional Gene Expression Profiling of Small Cell Lung Cancer Cells Cancer Res., April 15, 2003; 63(8): 1943 - 1953. [Abstract] [Full Text] [PDF]